Drug Discovery

#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: Transforming drug discovery with AI and digital labs

A new free to attend webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

Human brain
#Drug discovery #Multiple sclerosis #Neurodegenerative disorders #Neuroscience

Does EBV trigger multiple sclerosis and drive its progression?

Evelyn Peelen, Head of Research, Andreas Muehler, Chief Medical Officer, and Hella Kohlhof, Chief Scientific Officer at Immunic Therapeutics discuss the unmet need for MS treatments that combine neuroprotective, anti-inflammatory, and antiviral properties. For a long time, multiple sclerosis (MS) has been viewed as a disease driven solely by peripheral… Read More

#Exclusive Content

#AI #Dermatology #Drug discovery

Almirall and Absci extend partnership tackling dermatological conditions  

Biopharmaceutical companies Almirall and Absci have announced an expansion of their ongoing partnership targeting dermatological indications.   The expansion of the collaboration follows the successful delivery of AI-designed, functional antibody leads against a difficult-to-drug target—the first target addressed within the initial collaboration between Almirall and Absci.  … Read More

#News

#Artificial intelligence (AI) #Collaboration #Drug discovery #Peptides

AI-powered platform could accelerate peptide drug discovery

CRDMO BioDuro and Atombeat have announced a strategic collaboration on an AI powered platform for accelerated peptide drug discovery.  The collaboration brings together Atombeat’s in silico modeling, AI-accelerated and data-driven design platform with BioDuro’s discovery chemistry, biology and DMPK.  The combined platform aims… Read More

#News

#AI / data analytics / healthtech / informatics #Chromatography #Drug discovery

How data standards are revolutionising chromatography data workflows

Burkhard Schaefer, Managing Director of Splashlake, explores how chromatography is being impacted by emerging data standards. In drug discovery, every inefficiency in experimental workflows costs time, money, and the chance to bring life-saving treatments to patients. Chromatography has long been hampered by data silos, proprietary formats, and disconnected instrumentation. But… Read More

#Exclusive Content

Back pain
#Chronic low back pain #Chronic pain #Drug development #Non-opioid #Persica Pharmaceuticals

New podcast: A non-opioid approach to chronic low back pain

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Steve Ruston, CEO… Read More

#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #DMTA #Drug discovery

AI-augmented innovation: Enabling DMTA with digital-physical synergy

Andrew Anderson, Vice President, Innovation and Informatics Strategy at ACD/Labs, looks at how AI is enabling true drug design. Innovators in the pharma and biopharma sectors are actively seeking systems that accelerate the discovery, development, and commercialisation of new products. Of particular interest are systems to support the implementation of… Read More

#Exclusive Content

#Automation #Drug discovery #Lab technology #Labguru #Mergers and acquisitions #Titian

Labguru and Titian Software Rebrand as Cenevo

Titian Software and Labguru have rebranded as Cenevo, bringing together the two companies’ solutions, Labguru and Mosaic, under a new, unified brand.   The combined organisation specialises in lab management systems, automation, orchestration, data management and AI technology.  The new company says that Cenevo software will… Read More

#Business & Investment #News

#Alzheimer's #Drug discovery #Neurodegenerative disorders #Neuroscience

New DDW Highlights podcast: 4 August 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Alzheimer’s Association International Conference (AAIC) taking place this week in Toronto, Canada, there… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Non-animal model (NAM) #Organ-on-a-chip #Preclinical development

What comes after animal models?  

Mariana Argenziano, Associate Director Manufacturing Technologies, and Jeroen de Groot, Divisional Chief Executive Officer at Ncardia, explore how human-relevant preclinical research can move the industry past its reliance on animal models.   In April 2025, the US Food and Drug Administration (FDA) released a roadmap to reducing animal… Read More

#Exclusive Content

#Alzheimer's #Drug discovery #Neurodegenerative disorders #Neuroscience

This week in drug discovery (28 July – 1 August) 

News round-up for 28 July – 1 August by DDW Senior Digital Content Editor Diana Turner. With the Alzheimer’s Association International Conference (AAIC) taking place this week in Toronto, Canada, there have been a number of updates in the neuroscience drug discovery field. The top stories:… Read More

#News

#Biomedical research #Drug discovery #Spatial biology

Spatial biology: What you need to know about this revolutionary field

Dr Saška Brajkovic, Senior Director R&D, Lunaphore, Spatial Biology Division at Bio-Techne, explains how the spatial biology field is transforming our view of how various diseases function and leading to exciting new treatment possibilities. Spatial biology is rapidly gaining momentum across biomedical research. At the end of 2024, the field… Read More

#Exclusive Content

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

New DDW Highlights podcast: 28 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns,… Read More

#News

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

This week in drug discovery (21-25 July) 

News round-up for 21-25 July by DDW Senior Digital Content Editor Diana Turner. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns, manufacturing has dominated the headlines this week, particularly significant investment in facilities in the US, and new guidelines… Read More

#News